This batch is verified
If you are considering injections, consult a licensed clinician who can verify the sterility, sourcing, and safety protocols of their supply
The safety profile of cagrilintide, as observed in clinical trials , is primarily characterized by gastrointestinal disturbances , most notably mild to moderate nausea during the initial titration phase
However, headache incidence rates were similar between AOD-9604 and placebo groups, suggesting that many cases represented background occurrence rather than treatment-related effects
However, once opened, the vial should be used within 28 days to maintain safety and efficacy, after which it should be discarded
These help to defend the skin from environmental stressors